April 25, 2018 5:23 AM ET

Capital Markets

Company Overview of Oppenheimer & Co. Inc.

Company Overview

Oppenheimer & Co. Inc. offers investment banking, mutual fund advisory, securities research, and asset management services. The company's services include order execution, securities clearing, institutional equity sales and trading, and customer accounting. It deals in stocks, bonds, options and commodities and provides research analysis, investment advice, and support services. The company was founded in 1881 and is based in New York, New York. Oppenheimer & Co. Inc. operates as a subsidiary of Oppenheimer Holdings Inc.

85 Broad Street

New York, NY 10004

United States

Founded in 1881





Key Executives for Oppenheimer & Co. Inc.

Chairman & CEO
Age: 71
Executive VP & CFO
Age: 47
Head of Technology, Media & Communications Investment Banking and Managing Director
Head of U.S. Investment Banking & Global Fixed Income
Age: 40
Compensation as of Fiscal Year 2017.

Oppenheimer & Co. Inc. Key Developments

Oppenheimer & Co. Inc. Announces Gilbert Dychiao as Managing Director in the Financial Institutions Group

Oppenheimer & Co. Inc. announced Gilbert Dychiao joined the Firm as Managing Director in the Financial Institutions Group. The addition of Dychiao marks a significant expansion into financial institutions investment banking for Oppenheimer, which is an important growth area for the Firm. Prior to joining in the company, Dychiao was a Partner and Managing Director at Freeman & Co LLC. Prior to Freeman & Co, he was a Senior Banker in the Global Financial Institutions Group at Credit Suisse First Boston.

Oppenheimer & Co. Inc. Appoints Leland Gershell as Managing Director and Senior Analyst on Life Sciences Research Team

Oppenheimer & Co. Inc. announced Leland Gershell joined the firm as Managing Director and Senior Analyst on the Life Sciences research team. With extensive experience in the field, he is responsible for expanding and distinguishing the company's Life Sciences research product. Gershell joins from Capricor Therapeutics.

Oppenheimer & Co. Inc. Presents at BIO CEO & Investor Conference, Feb-12-2018 05:00 PM

Oppenheimer & Co. Inc. Presents at BIO CEO & Investor Conference, Feb-12-2018 05:00 PM. Venue: New York Marriott Marquis Hotel, 1535 Broadway, New York, New York, United States. Speakers: Stefan D. Loren, Managing Director, Healthcare Investment Banking.

Similar Private Companies By Industry

Company Name Region
@Visory LLC United States
1 Road Partners LLC United States
123Jump.com, Inc. United States
1509225 Ontario, Inc. United States
1650 Wealth Management, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Oppenheimer & Co. Inc., please visit www.opco.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.